Aimei Health Technology Co. Ltd (AFJK) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
10 EAST 53RD STREET NEW YORK, NY 10022 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 677 - Blank Checks (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 9/30/2024 MRQ | 12/31/2023 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 580,717 | |||
| Cash and cash equivalents | 580,717 | |||
| Prepaid expense | ||||
| Total current assets: | 580,717 | |||
| Noncurrent Assets | ||||
| Asset, held-in-trust | 69,889,848 | |||
| Total noncurrent assets: | 69,889,848 | |||
| TOTAL ASSETS: | 70,470,565 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 24,841 | |||
| Accrued liabilities | 24,841 | |||
| Other liabilities | ||||
| Total current liabilities: | 24,841 | |||
| Noncurrent Liabilities | ||||
| Liabilities, other than long-term debt | 690,000 | |||
| Deferred compensation liability, classified | 690,000 | |||
| Total noncurrent liabilities: | 690,000 | |||
| Total liabilities: | 714,841 | |||
| Temporary equity, carrying amount | 69,889,848 | |||
| Equity | ||||
| Equity, attributable to parent | (134,124) | |||
| Common stock | 213 | |||
| Accumulated deficit | (134,337) | |||
| Total equity: | (134,124) | |||
| TOTAL LIABILITIES AND EQUITY: | 70,470,565 | |||
Income Statement (P&L) (USD)
| 9/30/2024 TTM | 12/31/2023 | ||
|---|---|---|---|
| Operating expenses | |||
| Operating loss: | |||
| Nonoperating income (Investment Income, Nonoperating) | |||
| Net income available to common stockholders, diluted: | |||
Comprehensive Income (USD)
| 9/30/2024 TTM | 12/31/2023 | ||
|---|---|---|---|
| Net income: | |||
| Comprehensive income, net of tax, attributable to parent: | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.